Evidence map›Paper›PMID 39729805›Full record

ArticleDrug and alcohol dependence2025

Tobacco cessation, mental health, and substance use in a community pharmacist-linked cessation program for people experiencing homelessness.

Kaitlyn Kui, Christian Hailozian, Mable Thai, Deepalika Chakravarty, Dorie E Apollonio, Lisa Kroon, Maya Vijayaraghavan

Abstract readEvaluation Study
In one paragraph

Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kaitlyn KuiDepartment of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA.
Christian HailozianDepartment of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA.
Mable ThaiDepartment of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA.
Deepalika ChakravartyDivision of Prevention Science, University of California, San Francisco, CA, USA.
Dorie E ApollonioDepartment of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA.
Lisa KroonDepartment of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, CA, USA.
Maya VijayaraghavanUCSF Division of General Internal Medicine, University of California, San Francisco, CA, USA; Division of General Internal Medicine, San Francisco General Hospital, University of California, San Francisco, CA, USA. Electronic address: maya.vijayaraghavan@ucsf.edu.

Funding

Addressing disparities in tobacco-related diseases by understanding the tobacco industry strategiesR01CA268491 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STELLA AGUINAGA BIALOUS, Pamela May Ling · 2022 to 2026
$3.4M
NCI NIH HHS R01 CA268491
6 · The paper itself

Abstract

introductionThe prevalence of tobacco use among people experiencing homelessness is 70 %. Mental health and substance use disorders are associated with tobacco use and pose challenges for tobacco cessation.

methodsBetween 2019 and 2024, we recruited 206 adults experiencing homelessness from three homeless shelters in San Francisco, California. Participants were enrolled in a 12-week pharmacist-linked smoking cessation program that involved pharmacist counseling and furnishing of nicotine replacement therapy (NRT) and brief cessation coaching by trained shelter staff. We examined the association of provision of tobacco cessation interventions with two outcomes-weekly cigarette consumption and quit attempts-using mixed effects Poisson and logistic regression models respectively. We ran separate models with baseline mental health conditions and substance use disorders and adjusted for age, gender, race-ethnicity, time to first cigarette after waking, and baseline cigarette consumption in all models.

resultsAdjusting for baseline mental health conditions and other covariates, the use of pharmacist-furnished NRT was associated with lower weekly consumption (Incidence Rate Ratio [IRR]: 0.74, 95 % Confidence Interval [CI]: 0.71-0.76) and increased weekly quit attempts (Adjusted Odds Ratio (AOR): 1.78, 95 % CI: 1.23-2.58). After adjusting for baseline substances used and other covariates, use of pharmacist-furnished NRT was associated with lower weekly consumption (IRR: 0.74, 95 % CI: 0.73-0.76) and increased weekly quit attempts (AOR: 1.99, 95 % CI: 1.45-2.74).

conclusionsA community pharmacist-linked cessation program in homeless shelters was associated with reduced consumption and increased weekly quit attempts, highlighting its potential for scalability among people experiencing homelessness with high rates of co-occurring behavioral health conditions.

Indexed as

Ill-Housed PersonsMental DisordersSubstance-Related DisordersTobacco UseTobacco Use CessationAdultCommunity-Based Participatory ResearchCommunity Pharmacy ServicesCounselingDiagnosis, Dual (Psychiatry)FemaleHumansLogistic ModelsMaleMental HealthMentoringPeople Experiencing HomelessnessPharmacy-Linked Smoking Cessation ProgramTobacco cessation

Identifiers

PMID39729805
PMCPMC12978291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.